2025 ISAKOS Congress in Munich, Germany

ISAKOS 2025 Congress Abstract Author

 

Jeffrey S. Mun, BA

Massachusetts General Hospital, Department of Orthopaedic Surgery
UNITED STATES

Sun 06/08
13:55 - 14:00
Room 11 Videos and Papers: Orthobiologics
Paper
Outcomes Following Arthroscopic Labral Repair with and Without Bone Marrow Aspirate Concentrate Application: A Case Control Study with Minimum Five Year Follow Up
Author
Mon 06/09
11:10 - 11:15
Room 12 Videos and Papers: Hip Arthroscopy
Paper
Six Month Functional Scores Predict 5 Year Outcomes after Hip Arthroscopy
Author
Mon 06/09
14:20 - 14:25
Room 13a Afternoon Scientific Session I
Paper
All-Arthroscopic Capsular Autograft Hip Labral Reconstruction: Minimum 5 Year Outcomes
Author
Hall D
Wednesday & Thursday

Biologics
In-Person Poster
Bone Marrow Aspirate Concentrate Is a Cost-Effective Treatment for Preventing Conversion to Total Hip Arthroplasty Following Arthroscopic Acetabular Labral Repair
Author
ePosters
Hip/Groin/Thigh
E-Poster
Labral Tear Size As A Predictor Of Long-Term Outcomes And Conversion To Total Hip Arthroplasty: Minimum 8 Year Follow-Up
Author
ePosters
Hip/Groin/Thigh
E-Poster
A Comprehensive 6-Phase Prehabilitation And Rehabilitation Program For Patients Undergoing Endoscopic Repair Of Full-Thickness Gluteus Medius And/Or Minimus Tears
Author
ePosters
Hip/Groin/Thigh
E-Poster
Long-Term Hip Arthroscopy Survivorship Can Be Predicted By A Lateral/Medial Joint Space Ratio <1
Author
ePosters
Hip/Groin/Thigh
E-Poster
Os Acetabuli Do Not Portend Inferior 2-Year Functional Outcomes In Patients Undergoing Arthroscopic Acetabular Labral Repair
Author
ePosters
Hip/Groin/Thigh
E-Poster
Global Acetabular Retroversion Is Associated With Increased Conversion To Total Hip Arthroscopy After Primary Hip Arthroscopy: A Propensity-Matched Analysis With Minimum 8-Year Follow-Up
Author
ePosters
Biologics
E-Poster
Harvest And Application Of Bone Marrow Aspirate Concentrate From The Ilium During Hip Arthroscopy For Acetabular Labral Repair Is Safe And Reliable
Author

Disclosures

No Financial Conflicts to Disclose
All relevant financial disclosures have been mitigated.